Clinical Trials Browser

Phase NA × pembrolizumab × Gynecologic × Clear all

NCT06549855 2024-08-12

PD-1 Inhibitor Combined With Progesterone Treatment in FST for Patients With MMRd Endometrial Cancer

Phase NA Not yet recruiting

Turcot syndrome, Endometrial Neoplasms, Carcinoma, Endometrioid

NCT05368207 2024-03-13

Pemb-HT

Phase NA Active not recruiting

Ovarian Neoplasms, Carcinoma, Small Cell